Associate Director, Site Profiling and Institutional Insights

Position Overview

• Location Type:
• Job Type: Regular, Full-Time Employee
• Salary:

Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks. With their purified, high-precision investigational cell therapies, Orca Bio aims to not only replace patients' blood and immune systems with healthy ones but also restore their lives.

The (Associate) Director of Site Profiling & Institutional Insights will play a pivotal role in the successful launch and commercialization of ORCA-T by leading the development, execution, and continuous refinement of Orca Bio’s treatment center profiling strategy. This individual will be responsible for designing and maintaining a scalable institutional profiling framework that enables prioritized site onboarding, tailored activation plans, and informed commercial execution. Acting as the center of excellence for institutional intelligence, this role integrates across market enablement, technical operations, sales, commercial operations, medical affairs, and forecasting to drive insight-based decision-making.

Responsibilities

Site Profiling & Prioritization

• Develop and manage a national profiling program to assess treatment center readiness, capabilities, transplant volume, infrastructure, decision-making structures, and willingness to adopt ORCA-T.
• Apply deep knowledge of Orca-T’s product supply chain and the patient journey to inform site profiling and prioritization strategies.
• Lead qualitative and quantitative data collection via surveys, site interviews (virtual and in-person), CRM input, and cross-functional intelligence.
• Create and continuously refine a segmentation model to guide site prioritization and onboarding sequence based on factors such as commercial impact, operational feasibility, and institutional dynamics.

Tailored Activation Planning

• Partner with the Market Enablement function to translate site profiles into customized onboarding playbooks and execution tracks, ensuring alignment with a site’s capabilities and constraints.
• Identify and document activation risk factors and recommend site-specific mitigation strategies for infrastructure, staffing, education, or process gaps.
• Deliver comprehensive site intelligence to onboarding teams ahead of and during activation, ensuring they are equipped with the necessary context, contacts, and tactical insights to execute effectively.

Field Strategy Integration

• Collaborate with Sales, Field Market Access, and Customer Experience function to provide actionable insights that inform account planning, stakeholder mapping, and engagement tactics.
• Maintain and update institutional profiles, and make them accessible within CRM tools, ensuring information is accurate, current, and aligned with each center’s progress through onboarding and post-launch operations.
• Proactively identify and escalate institutional barriers or accelerators that impact field execution, ensuring timely resolution or leverage through cross-functional coordination.

Forecasting & Operational Readiness

• Deliver institutional ramp-up and throughput assumptions to the Forecasting and Commercial Analytics function.
• Participate in cross-functional launch planning, ensuring site-specific onboarding timelines and constraints are reflected in demand models and operational readiness frameworks.
• Track and refine institutional adoption curves using live profiling data and post-onboarding metrics.

Market Intelligence & Lifecycle Monitoring

• Maintain dynamic “living profiles” of treatment centers that evolve post-activation, incorporating ongoing insights around site behavior.

Company Information

Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks. With their purified, high-precision investigational cell therapies, Orca Bio aims to not only replace patients' blood and immune systems with healthy ones but also restore their lives.